Patents by Inventor Claudia Cozma

Claudia Cozma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the diagnosis of Farber's disease
    Patent number: 11204357
    Abstract: The present invention is related to a method for diagnosing Farber's disease in a subject, wherein the method comprises detecting C26 ceramide in a sample from the subject.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: December 21, 2021
    Assignee: Centogene GmbH
    Inventors: Arndt Rolfs, Claudia Cozma
  • Use of Lyso-GB1 as Druggable Target
    Publication number: 20210379205
    Abstract: The present invention is related to the in vitro use of lyso-Gb1 as a draggable target in the development of a drug, and to antagonist of lyso-Gb1 for use in the treatment and/or prevention of a disease, wherein the disease is Gaucher disease or Parkinson's disease
    Type: Application
    Filed: August 20, 2021
    Publication date: December 9, 2021
    Inventors: Claudia Cozma, Peter Bauer
  • Use of lyso-Gb1 as druggable target
    Patent number: 11097016
    Abstract: The present invention is related to the in vitro use of lyso-Gb1 as a draggable target in the development of a drug, and to antagonist of lyso-Gb1 for use in the treatment and/or prevention of a disease, wherein the disease is Gaucher disease or Parkinson's disease.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: August 24, 2021
    Assignee: Centogene GmbH
    Inventors: Claudia Cozma, Peter Bauer
  • Method for the Diagnosis of Hereditary Angioedema
    Publication number: 20200355700
    Abstract: The present invention is related to a method for differential diagnosis of hereditary angioedema, wherein the method comprises determining the level of C4 protein, C1-INH protein and C1q protein in a sample from a subject, wherein the sample is a dried blood spot sample and wherein the level is determined by mass spectrometry.
    Type: Application
    Filed: January 31, 2019
    Publication date: November 12, 2020
    Inventor: Claudia Cozma
  • USE OF LYSO-GB1 AS DRUGGABLE TARGET
    Publication number: 20190201554
    Abstract: The present invention is related to the in vitro use of lyso-Gb1 as a draggable target in the development of a drug, and to antagonist of lyso-Gb1 for use in the treatment and/or prevention of a disease, wherein the disease is Gaucher disease or Parkinson's disease.
    Type: Application
    Filed: July 3, 2017
    Publication date: July 4, 2019
    Applicant: Centogene AG
    Inventors: Claudia COZMA, Peter BAUER
  • Method for the Diagnosis of Cystic Fibrosis
    Publication number: 20190128901
    Abstract: The present invention is related to a method for diagnosing cystic fibrosis in a subject comprising a step a), wherein the step a) comprises detecting a biomarker in a sample from the subject, wherein the sample is a sample selected from the group comprising blood, a blood product, urine, saliva, cerebrospinal liquid, stool, tissue and lymph liquid.
    Type: Application
    Filed: April 24, 2017
    Publication date: May 2, 2019
    Applicant: Centogene IP GmbH
    Inventor: Claudia Cozma
  • Method for the Diagnosis of Farber's Disease
    Publication number: 20180203024
    Abstract: The present invention is related to a method for diagnosing Farber's disease in a subject, wherein the method comprises detecting C26 ceramide in a sample from the subject.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 19, 2018
    Applicant: CENTOGENE AG
    Inventors: Arndt Rolts, Claudia Cozma